Newer therapies are increasingly targeting multiple hormone pathways at once in an effort to improve: fat reduction, insulin sensitivity, metabolic flexibility, body composition, and overall metabolic health
Other potential risks include: Gastrointestinal adverse effects nausea, vomiting, and diarrhoea are recognised class effects of GLP-1 receptor agonists (as documented in the Wegovy [semaglutide] Summary of Product Characteristics [SmPC] available via the electronic Medicines Compendium [emc])
This triple mechanism does not treat a disease endpoint it reprograms the metabolic environment in which obesity, type 2 diabetes, MASH, cardiovascular disease, and multiple chronic conditions emerge and progress
Whether youre taking a GLP-1 medication or simply trying to support your bodys natural GLP-1 production, the nutritional advice remains largely the same: prioritise protein, fibre, healthy fats, and minimally processed whole foods